Cell and Gene Therapy Market Size to Reach over $14 Billion by 2025 - Arizton

In-depth analysis and data-driven insights on the impact of COVID-19 included in this global cell and gene therapy market report

News provided by

Arizton Advisory & Intelligence

Jul 30, 2020, 09:00 ET

CHICAGO, July 30, 2020 /PRNewswire/ -- The global cell and gene therapy market is expected to grow at a CAGR of over 30% during the period 2019−2025.

Key Highlights Offered in the Report:

The CAR T-cell therapy is gaining popularity in recent years due to its highly personalized nature of the therapy and the utilization of the advanced technology; the vendors have increased focus towards the product introduction in the CAR T Cell therapy. Recently in 2020, the FDA approved Tecartus, cell-based gene therapy to treat relapsed or refractory MCL in adults.
Vendors are focusing to develop and launch new products in the market to remain competitive in the market. The product approvals and launches have increased recently in the market.
The US is dominating the global cell and gene therapy market with highest absolute growth of more than 500% and growing at a CAGR of around 36%.
The demand for regenerative medicines has increased across the globe. The investments for cell and gene therapy have increased from both the public and private institutes for the infrastructure, R&D, and providing the accelerated procedure for the product approvals.
Currently cell therapy dominates the market, however this trend is about to change by 2025, gene therapy dominated the market with a share of around 75% in 2019. This is due to the increased number of product approvals during the forecast period.
Currently the global players are focusing towards inorganic growth by acquiring the smaller biotech companies which helps to enhance the product portfolio and increase the market share in the cell and gene therapy market.

Key Offerings:

Market Size & Forecast by Revenue | 2019−2025
Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities
Market Segmentation – A detailed analysis by product, disease, end-user, and geography
Competitive Landscape – 8 key vendors and 30 other vendors

Get your sample today! https://www.arizton.com/market-reports/cell-and-gene-therapy-market

Cell and Gene Therapy Market – Segmentation

The gene therapy segment is expected to witness the fastest growth than cell therapy in the market. The high potential of treating diseases through gene therapies makes them more demanding than cell therapies. However, the lack of reimbursement is one of the significant challenges is limiting the usage of the cell and gene therapy segments.
In 2019, the oncology segment accounted for a share of over 40% in the global cell and gene therapy market. Oncology has been one of the targets of intense research for the gene therapy procedures & approach. More than 60% of on-going gene therapy clinical trials are targeting cancer.
In 2019, the wound care segment accounted for a share of over 16% in the global market. Most patients suffer from chronic wounds such as diabetic ulcers, pressure ulcers, and venous stasis ulcers, cause significant morbidities in millions of patients per year. Hence, individuals who have diabetes for a long period develop both peripheral vascular disease and peripheral neuropathy.

Cell and Gene Therapy Market by Product

Cell Therapy
Gene Therapy

Cell and Gene Therapy Market by Disease

Dermatology
Musculoskeletal
Oncology
Genetic Disorders
Others

Cell and Gene Therapy Market by End-user

Hospitality
Cancer Care Centers
Wound Care Centers
Ambulatory Surgical Centers
Others

Cell and Gene Therapy Market – Dynamics

Cell & gene therapies are emerging as the most dynamic field in medicine with a lot of ongoing R&D. Various components under cell & gene therapy such as injectable-based cell therapy, tissue-based products, vector-based gene therapy, and cell-based immunotherapy are witnessing cutting edge research to advance the clinical indications for these products. Vendors are actively conducting clinical trials to gain regulatory approval in different countries and regions with huge untapped potential.

Key Drivers and Trends fueling Market Growth:

Increase in Strategic Acquisitions
Increased Funding for Cell & Gene Therapy Products
Increasing Pool of Target Population
Growing Demand for CAR T-Cell Therapies

Cell and Gene Therapy Market – Geography

North America dominated the market and plays an important role in the adoption of cell & gene therapies. However, the initial product development and approvals started in China, Japan, and Europe. Post the approval of medicines in the US in 2017, the market in North America witnessed faster growth, and funds across the globe started flowing into clinical trials in the region. Many vendors started acquiring smaller companies to enter the North American region.

Get your sample today! https://www.arizton.com/market-reports/cell-and-gene-therapy-market

Cell and Gene Therapy Market by Geography

North America

US
Canada

Europe

UK
Germany
France
Spain
Italy

APAC

China
Japan
South Korea
Australia
India

Latin America

Brazil
Mexico

Middle East & Africa

Saudi Arabia
Turkey
South Africa
UAE

Prominent Vendors

Gilead Sciences
Spark Therapeutics
Novartis
Organogenesis
Amgen
Osiris Therapeutics
Dendreon
Vericel

Other Prominent Vendors

Antergen
Tego Sciences
Japan Tissue Engineering
JCR Pharmaceuticals
Medipost
MolMed
AVITA Medical
CollPlant
Biosolution
Stempeutics Research
Kolon Tissue Gene
Orchard Therapeutics
Sibiono GeneTech
NuVasive
Corestem
Pharmicell
Shanghai Sunway Biotech
RMS Regenerative Medical System
Takeda Pharmaceutical Company
CHIESI Farmaceutici
CO.DON
AnGes
GC Pharma
Human Stem Cells Institute
JW CreaGene
APAC Biotech
Nipro
Terumo
Orthocell
bluebird bio

Explore our healthcare & lifesciences profile to know more about the industry.

Read some of the top-selling reports:

About Arizton:

Arizton Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.

We offer comprehensive market research reports on industries such as consumer goods & retail technology, automotive and mobility, smart tech, healthcare, and life sciences, industrial machinery, chemicals and materials, IT and media, logistics and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.

Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.

Mail: [email protected]
Call: +1-312-235-2040
+1-302-469-0707

SOURCE Arizton Advisory & Intelligence